BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liang L, Wu X, Shi C, Wen H, Wu S, Chen J, Huang C, Wang Y, Liu Y. Synthesis and characterization of polypyridine ruthenium(II) complexes and anticancer efficacy studies in vivo and in vitro. J Inorg Biochem 2022;236:111963. [PMID: 35988387 DOI: 10.1016/j.jinorgbio.2022.111963] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Silva HVR, da Silva GÁF, Zavan B, Machado RP, de Araujo-neto JH, Ellena JA, Ionta M, Barbosa MIF, Doriguetto AC. The nicotinamide ruthenium(II) complex induces the production of reactive oxygen species (ROS), cell cycle arrest, and apoptosis in melanoma cells. Polyhedron 2023;231:116267. [DOI: 10.1016/j.poly.2022.116267] [Reference Citation Analysis]
2 Wang Y, Li Y, Chen J, Liu H, Zhou Y, Huang C, Liang L, Liu Y, Wang X. Anticancer effect evaluation of iridium(III) complexes targeting mitochondria and endoplasmic reticulum. Journal of Inorganic Biochemistry 2023;238:112054. [DOI: 10.1016/j.jinorgbio.2022.112054] [Reference Citation Analysis]
3 Dömötör O, Teixeira RG, Spengler G, Avecilla F, Marques F, Lenis-rojas OA, Matos CP, de Almeida RF, Enyedy ÉA, Tomaz AI. Ruthenium(II) polypyridyl complexes with benzothiophene and benzimidazole derivatives: Synthesis, antitumor activity, solution studies and biospeciation. Journal of Inorganic Biochemistry 2022. [DOI: 10.1016/j.jinorgbio.2022.112058] [Reference Citation Analysis]